CASC2 and central nervous system cancer: LncRNA cancer susceptibility candidate 2 (CASC2), a novel tumor suppressor, modulates cell migration, invasion, proliferation, apoptosis and tumor growth in multiple human cancers, such as renal cell carcinoma, gastric cancer, non-small cell lung cancer, endometrial cancer, colorectal cancer and glioma [9–12].